Weimin Mao
Papers
1
Total Citations
2
H-Index
1
About
Weimin Mao is a leading hepatobiliary surgeon whose research focuses on advancing minimally invasive surgical techniques for liver cancer, particularly hepatocellular carcinoma (HCC). His major contributions center on evaluating the safety, efficacy, and long-term outcomes of robotic hepatectomy compared to traditional open surgery. In his landmark 2025 study, Mao led a large-volume, propensity score-matched analysis comparing robotic versus open hepatectomy for large HCC tumors (≥5 cm), demonstrating that the robotic approach can achieve comparable oncologic outcomes with reduced perioperative morbidity. This work, already garnering 2 citations shortly after publication, provides critical evidence for expanding minimally invasive options in complex liver resections. Mao’s research addresses a pressing clinical need—optimizing surgical strategies for patients with sizable tumors who historically required open procedures. By systematically analyzing perioperative and long-term results, he helps define best practices for robotic liver surgery, directly influencing surgical decision-making in high-volume centers. His ongoing contributions continue to shape the evolution of hepatobiliary surgery, offering patients less invasive alternatives without compromising cancer outcomes.
Research Focus
Key Achievements
Top Papers
- 1